Demographic data of 29 patients in cohort 2 and 14 patients in cohort 3.
| Clinical Characteristics | Cohort 2, n = 29 | Cohort 3, n = 14 |
|---|---|---|
| Age, yrs, median (range) | 60 (31–76) | 61.5 (43–86) |
| Mean (SD) | 57.9 (11.2) | 62.0 (13.5) |
| Myositis duration, yrs, median (range) | 5 (1–22) | 11.5 (5–43) |
| Mean (SD) | 6.1 (5.3) | 15.4 (10.9) |
| Creatine kinase, U/L, median (range) | 102 (43–850) | 97 (47–1470) |
| Sex, female | 19 (66) | 10 (71) |
| Diagnosis | ||
| PM | 6 (21) | 11 (79) |
| DM | 15 (52) | 3 (21) |
| Antisynthetase syndrome | 8 (28) | 0 (0) |
| MAP score, median (range) | 2 (1–5) | 2 (1–5) |
| HAQ score, median (range) | 0.8 (0–2) | 0.6 (0–2) |
Values are n (%) unless otherwise specified. DM: dermatomyositis; HAQ: Health Assessment Questionnaire; MAP: Myositis Activities Profile; PM: polymyositis.